Iris Otoya-Fernandez

3PUBLICATIONS
19CO-AUTHORS
Midwifery not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 24, 2025
Influence of HER2 Changes on Survival Outcomes After Neoadjuvant Chemotherapy in Peruvian Patients With Triple-Negative Breast Cancer.

Zaida Morante, Yomali Ferreyra, Iris Otoya

|Jul 04, 2024
Subcutaneous Trastuzumab: An Observational Study of Safety and Tolerability in Patients With Early HER2-Positive Breast Cancer.

Iris Otoya, Natalia Valdiviezo, Zaida Morante

|Nov 11, 2022
The impact of telemedicine on cancer care: real-world experience from a Peruvian institute during the COVID-19 pandemic.

Katia Roque, Rossana Ruiz, Iris Otoya-Fernandez

Pageof 1

Frequent Collaborators

3 joint publications

Tatiana Vidaurre

3 joint publications

Silvia P Neciosup

3 joint publications

Henry L Gomez

2 joint publications

Natalia Valdiviezo